These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pyrimidine Pathway-Dependent and -Independent Functions of the Toxoplasma gondii Mitochondrial Dihydroorotate Dehydrogenase. Hortua Triana MA; Cajiao Herrera D; Zimmermann BH; Fox BA; Bzik DJ Infect Immun; 2016 Oct; 84(10):2974-81. PubMed ID: 27481247 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis. He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224 [TBL] [Abstract][Full Text] [Related]
8. Identification of Dihydroorotate Dehydrogenase Inhibitors Using the Cell Painting Assay. Schölermann B; Bonowski J; Grigalunas M; Burhop A; Xie Y; Hoock JGF; Liu J; Dow M; Nelson A; Nowak C; Pahl A; Sievers S; Ziegler S Chembiochem; 2022 Nov; 23(22):e202200475. PubMed ID: 36134475 [TBL] [Abstract][Full Text] [Related]
9. A Patent Review of Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors as Anticancer Agents and their Other Therapeutic Applications (1999-2022). Gehlot P; Vyas VK Recent Pat Anticancer Drug Discov; 2024; 19(3):280-297. PubMed ID: 37070439 [TBL] [Abstract][Full Text] [Related]
11. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. Mullen NJ; Thakur R; Shukla SK; Chaika NV; Kollala SS; Wang D; He C; Fujii Y; Sharma S; Mulder SE; Sykes DB; Singh PK Cancer Lett; 2023 Jan; 552():215981. PubMed ID: 36341997 [TBL] [Abstract][Full Text] [Related]
12. The pathway to pyrimidines: The essential focus on dihydroorotate dehydrogenase, the mitochondrial enzyme coupled to the respiratory chain. Löffler M; Carrey EA; Knecht W Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1281-1305. PubMed ID: 32043431 [TBL] [Abstract][Full Text] [Related]
13. Dihydro-orotate dehydrogenase is physically associated with the respiratory complex and its loss leads to mitochondrial dysfunction. Fang J; Uchiumi T; Yagi M; Matsumoto S; Amamoto R; Takazaki S; Yamaza H; Nonaka K; Kang D Biosci Rep; 2013 Feb; 33(2):e00021. PubMed ID: 23216091 [TBL] [Abstract][Full Text] [Related]
14. Nucleotide Limitation Results in Impaired Photosynthesis, Reduced Growth and Seed Yield Together with Massively Altered Gene Expression. Bellin L; Melzer M; Hilo A; Garza Amaya DL; Keller I; Meurer J; Möhlmann T Plant Cell Physiol; 2023 Dec; 64(12):1494-1510. PubMed ID: 37329302 [TBL] [Abstract][Full Text] [Related]
15. Functional expression of human dihydroorotate dehydrogenase (DHODH) in pyr4 mutants of ustilago maydis allows target validation of DHODH inhibitors in vivo. Zameitat E; Freymark G; Dietz CD; Löffler M; Bölker M Appl Environ Microbiol; 2007 May; 73(10):3371-9. PubMed ID: 17369345 [TBL] [Abstract][Full Text] [Related]
16. Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides. Löffler M; Jöckel J; Schuster G; Becker C Mol Cell Biochem; 1997 Sep; 174(1-2):125-9. PubMed ID: 9309676 [TBL] [Abstract][Full Text] [Related]
17. The Warburg effect modulates DHODH role in ferroptosis: a review. Amos A; Amos A; Wu L; Xia H Cell Commun Signal; 2023 May; 21(1):100. PubMed ID: 37147673 [TBL] [Abstract][Full Text] [Related]
18. DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia. Sexauer AN; Alexe G; Gustafsson K; Zanetakos E; Milosevic J; Ayres M; Gandhi V; Pikman Y; Stegmaier K; Sykes DB Blood Adv; 2023 Nov; 7(21):6685-6701. PubMed ID: 37648673 [TBL] [Abstract][Full Text] [Related]
19. Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models. Jones SW; Penman SL; French NS; Park BK; Chadwick AE Toxicol In Vitro; 2021 Apr; 72():105096. PubMed ID: 33460737 [TBL] [Abstract][Full Text] [Related]
20. SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitor. Baiazitov RY; Qi H; Arasu T; Lennox W; Cao L; Weetall M; Furia B; Zhuo J; Choi S; Kim MJ; Sheedy J; Davis T; Moon YC Eur J Med Chem; 2022 Dec; 244():114826. PubMed ID: 36242990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]